Patient Assistance Programs From Pharma Companies Need Streamlining, US Senators Say

 
• By Sue Sutter

BMS CEO Boerner acknowledged the complexity of patient assistance programs, and the need for simplification, during a Senate hearing. CEOs of J&J and Merck also tout their patient assistance programs as showing the firms’ commitment to helping patients access drugs they cannot afford.

Dog agility
Bristol Myers Squibb is looking at how many hoops patients have to jump through to access copay assistance. • Source: Shutterstock

More from Pricing Debate

More from Market Access